Cancer Registry Software Market Size, Share, and Trends 2024 to 2034

Cancer Registry Software Market Size and Growth 2024 to 2033

The global cancer registry software market size was valued at USD 59.02 million in 2023 and is expected to surpass around USD 143.62 million by 2033, growing at a CAGR of 9.3% from 2024 to 2033. 

Cancer Registry Software Market Key Takeaways

• North America led the global market with the highest market share of 33.64% in 2023.
• By software, the standalone segment has held the largest market share in 2023.
• By deployment model, the on-premise segment captured the biggest revenue share in 2023.
• By component, the commercial segment registered the maximum market share in 2023.

U.S. Cancer Registry Software Market Size and Growth 2024 to 2033

The U.S. cancer registry software market size was estimated at USD 13.92 million in 2023 and is predicted to be worth around USD 35.94 million by 2033, at a CAGR of 9.9% from 2024 to 2033.

North America dominated the cancer registry software market in 2023. The U.S. dominated the cancer registry software market in North America region. The North America region has presence of major market players operating in the cancer registry software market. The cancer registry software market in this region is growing due to the rising prevalence of cancer. In addition, due to high investments in the technology, the demand for cancer registry software is rising on a large scale in North America.

Asia-Pacific, on the other hand, is expected to develop at the fastest rate during the forecast period. The government of emerging nations such as Japan and China are taking constant efforts for the development of the cancer registry software market. Moreover, the key market players are collaborating with the government agencies for the expansion of the healthcare sector. This factor is driving the growth of the cancer registry software market in Asia-Pacific region.

Europe Cancer Registry Software Market Size and Growth 2024 to 2033

The Europe cancer registry software market size was calculated at USD 16.00 million in 2023 and is projected to expand around USD 41.08 million by 2033, poised to grow at a CAGR of 9.9% from 2024 to 2033.

Cancer Registry Software Market Growth Factors

The cancer registry software is database or an information system which helps to collect the information regarding cancer patients. One of the key factors driving the growth of the global cancer registry software market is growing incidence of cancer globally. The cancer registry software helps to track and monitor the health of patients who are suffering from cancer. The data collected with the help of cancer registry software helps researchers and healthcare practitioners to develop therapeutics for the treatment of cancer. Thus, the global cancer registry software market is expected to grow in the coming years.

In addition, the growing geriatric population is also driving the growth of the cancer registry software market over the forecast period. The data collected from the cancer registry software helps to control the cancer from spreading all around the world. This software also helps government to track the patients in a particular location and region. As a result, this factor is supporting the growth of the global cancer registry software market.

Another factor boosting the growth of the global cancer registry software market is adoption of advanced technology. The electronic health records are also utilized tremendously for keeping track of the data. Thus, the cancer registry software is being adopted on a large scale across all research centers and healthcare centers. Furthermore, the government of developed and developing countries is taking constant efforts for the growth of the global cancer registry software market during the forecast period.

On the other hand, the data privacy and security are one of the biggest challenges for the growth of the global cancer registry software market. The data and information collected with the help of cancer registry software can be easily hacked and this data can be misused by hackers. Thus, this factor is hindering the cancer registry software market.

Cancer Registry Software Market Scope

Software Insights

The standalone segment dominated the cancer registry software market in 2023. The standalone cancer registry software is integrated with latest and advanced features. It is also easy to use and operate. The standalone cancer registry software also helps in the reduction of overhead costs. Thus, all of these factors are propelling the growth of the segment.

The integrated segment is expected to witness strong growth during the forecast period. The integrated cancer registry software helps to collaborate with the hospitals’ software. This software helps to locate patients in any location. The integrated cancer registry software also assists to track and monitor the health of patients.

Deployment Model Insights

The on-premise segment dominated the cancer registry software market in 2023. The on-premise cancer registry software is mostly adopted by research institutes who are doing research on cancer. The on-premise cancer registry software is embedded with advanced features which help to store data easily. The on-premise cancer registry software is less risky as compared to other types of models. Thus, the on-premise cancer registry software is widely used in hospitals and research centers.

The cloud-based segment is fastest growing segment of the cancer registry software market in 2023. The cloud-based cancer registry software can be integrated with the real time data and standard guidelines. This software helps in the reduction of information technology overhead costs. In addition, the cloud-based cancer registry software is efficient in nature, which is driving the growth of the segment.

Component Insights

The commercial segment dominated the cancer registry software market in 2023. The data stored in the commercial database is quite safe as compared to public database. The data stored in the commercial database can be easily tracked. The commercial database can be used across research centers and government agencies. Thus, the commercial segment is rising at a rapid pace.

The public segment is fastest growing segment of the cancer registry software market in 2023. The public database is used for the various cancer research programs. The utilization of public database is growing due to the growing number of research centers all over the globe. The public database can help to track patient data from any corner of the world.

End Use Insights

The government and third-party segment dominated the cancer registry software market in 2023. The government of established and emerging nations is adopting cancer registry software on the large scale. This software helps to track and monitor cancer patients in their respective region. In addition, the investments made by government for the implementation of cancer registry software in hospitals. This factor is boosting the growth of the global cancer registry software market over the forecast period. 

The research institutes segment is fastest growing segment of the cancer registry software market in 2023. The cancer registry software is widely used in research institutes due to growing prevalence of cancer. The growing research and development initiatives by biotechnology and pharmaceutical industry players are also driving the growth of the global cancer registry software market.

Cancer Registry Software Market Recent Developments

• ArborMetrix Inc. U.S. announced a partnership with the Society of Interventional Radiology in June 2020. The goal of this collaboration is to provide the IR Quality Registry, which will integrate analytics to enhance patient care.
• COVID-19 registration platform and technology powered trial matching solution was launched by IQVIA Holdings Inc. in April 2020.
• Elekta partnered with PalabraApps LLC in April 2018 to develop the software that powers its MOSAIQ Oncology Information System.
• Onco Inc. increased its revenue in November 2018 by upgrading Oncology Version 4.4.0 to meet new CoC, AJCC 8^th, SEER, NAACCR 18, and STORE standards.

Cancer Registry Software Market Companies

• Rocky Mountain Cancer Data Systems
• McKesson Corporation
• Onco Inc.
• Elekta AB
• IBM Corporation
• C/Net Solutions
• Ordinal Data Inc.
• Himagine Solutions Inc.
• Electronic Registry Systems Inc.
• CONDUENT Inc.

Segments Covered in the Report

By Software

• Cross disciplinary
• Specific

By Deployment Model

• On-premise
• Cloud-based

By Component

• Commercial
• Public

By End Use

• Government and third party
• Private payers
• Hospital and medical practice
• Pharma biotech and medical device companies
• Research institutes

By Functionality

• Cancer Reporting to Meet State & Federal Regulations
• Patient Care Management
• Product Outcome Evaluation
• Medical Research and Clinical Studies

By Geography

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Malaysia
• Philippines
• Latin America
• Brazil
• Rest of Latin America
• Middle East & Africa (MEA)
• GCC
• North Africa
• South Africa
• Rest of the Middle East & Africa